FDA Inspection 1027128 — Tissue Transplant Technology, Ltd.

Tissue Transplant Technology, Ltd. — FEI 3000779542

The FDA completed an inspection of Tissue Transplant Technology, Ltd. on August 9, 2017 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 9, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
San Antonio, TX (United States)